✦ LIBER ✦

Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: Differential diagnosis between refractory anemia and aplastic anemia

✍ Scribed by Takashi Iwasaki; Masashi Murakami; Chiho Sugisaki; Sayaka Sobue; Haruhiko Ohashi; Haruhiko Asano; Motoshi Suzuki; Shigeo Nakamura; Masafumi Ito; Takashi Murate

Book ID: 115175928
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 381 KB
Volume: 58
Category: Article
ISSN: 1320-5463
DOI: 10.1111/j.1440-1827.2008.02236.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to ‘Quantification of marrow CD34+

Reply to ‘Quantification of marrow CD34+ cells: an important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia’ by A Orazi

✍ Matsui, W H; Brodsky, R A; Smith, B D; Borowitz, M J; Jones, R J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

(F9) A phase I trial of recombinant huma

(F9) A phase I trial of recombinant human interleukin-3 (rhIL-3) in patients with myelodysplastic syndrome (MDS) and aplastic anemia (AA) : A. Gillio, C. Gasparetto, T. Small, B. Childs, L. Reilly, V. Arasi, D. Young, F. Oldham, P. Nadler, M. Moore, R.J. O'Reilly, H. Castro-Malaspina. Memorial Sloan-Kettering Cancer Center, New York, NY and Sandoz Pharm. Corp., Hanover, NJ

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 142 KB